Merck & Company Inc. (MRK) Fundamentals

Merck makes pharmaceutical products to treat several conditions in a number of therapeutic areas, including cardiometabolic disease, cancer, and infections. Within cancer, the firm's immuno-oncology platform is growing as a major contributor to overall sales. The company also has a substantial vaccine business, with treatments to prevent hepatitis B and pediatric diseases as well as HPV and shingles. Additionally, Merck sells animal health-related drugs. From a geographical perspective, just under half of the firm's sales are generated in the United States.
SHARE INFORMATION
Market Cap$ 229,489,821,159
Shares Outstanding2,533,279,845
Float2,531,794,056
Percent Float99.94%
Short Interest0.00
Short Percent Float0.0%
Short Interest Ratio0.00
Short Interest Date-
Latest Fiscal Dividend Per Share$ 2.64
Latest Fiscal Revenue$ 50,157,000,000
Latest Fiscal EPS$ 5.14
Latest Fiscal Date2021-12-31
DIVIDENDS
Dividend (3 Years)$ 7.86
Dividend (5 Years)$ 7.89
Ex Dividend Date2022-09-14
Dividend Rate$ 2.76
Dividend Yield3.05%
Payment CashCash
HOLDERS
Institutions4,719
Institutional Holdings Date2022-07-31
Institutional Bought Previous 3 Months114,051,497
Institutional Holdings Percent130.8%
Institutional Sold Previous 3 Months247,405,990
Insider Holdings Date2022-07-31
Insider Bought Previous 3 Months787,154
Insider Holdings Percent0.1
Insider Sold Previous 3 Months24,653
Insider Shares Owned3,699,057
TRADING INFO
52 Week High$ 95.72
52 Week Low$ 70.89
52 Week High Change$ 20.43
21 Day Moving Average$ 89.5676
21 Day Extended Moving Average$ 89.8559
50 Day Moving Average$ 90.0874
50 Day Extended Moving Average$ 89.8568
200 Day Moving Average$ 82.9157
200 Day Extended Moving Average$ 85.2761
10 Day Average Volume8,619,498
20 Day Average Volume8,798,055
30 Day Average Volume8,610,356
50 Day Average Volume10,423,249
Alpha0.006853
Beta0.3127
Standard Deviation0.058385
R20.071751
7 Day Price Change$ 1.07
7 Day Percent Change1.2%
21 Day Price Change$ -0.70
21 Day Percent Change-0.77%
30 Day Price Change$ -4.37
30 Day Percent Change-4.6%
Month to Date Price Change$ 1.25
Month to Date Percent Change1.4%
Quarter to Date Price Change$ -0.58
Quarter to Date Percent Change-0.64%
180 Day Price Change$ 14.67
180 Day Percent Change19.33%
200 Day Price Change$ 11.05
200 Day Percent Change13.9%
Year to Date Price Change$ 15.24
Year to Date Percent Change20.23%

Merck & Company Inc. (MRK) Key Ratios

PROFITABILITY
EBIT Margin34.0%
EBITDA Margin40.3%
Pre-Tax Profit Margin13.6%
Profit Margin Count29.0%
Gross Margin70.4%
Profit Margin TOT29.0%
INCOME STATEMENTS
Revenue$ 57,169,000,000
Revenue Per Share$ 22.5672
Revenue (3 Years)$ 0.00
Revenue (5 Years)$ 0.00
FINANCIAL STRENGTH
Price to Tangible Book-491.50
Total Debt To Equity0.70
Int Coverage21.90
Current Ratio1.40
Leverage Ratio2.60
Quick Ratio0.90
Long Term Debt To Capital0.40
VALUATION MEASURES
PE Ratio13.90
Enterprise Value$ 251,050,153,957
Price to Sales4.0142
Price to Free Cash-62.50
PE High Last 5 Years87.90
Price To Book5.30
Price To Cash Flow12.20
PE Low Last 5 Years16.30
Price to Tangible Book-491.50
MANAGEMENT EFFECTIVENESS
Receivables Turnover7.10
Invoice Turnover2.70
Assets Turnover0.60
Return Assets17.71
Return on Equity45.63
Return on Capital25.75

Merck & Company Inc. (MRK) Profile

PROFILE INFO
Issue TypeCS
SEC TypeEQS
AuditorPricewaterhouseCoopers LLP
CEORobert M. Davis
Emplyoees68000
Last AuditUQ
CIK0000310158
IndustryDrug Manufacturers
SectorHealthcare
NAICSPharmaceutical Preparation Manufacturing(325412)
CONTACT INFO
Address2000 Galloping Hill Road
Kenilworth, NJ 7033
Websitehttps://www.merck.com
Facsimile-
Telephone+1 908 740-4000
Emailinvestor_relations@merck.com


Your Recent History
NYSE
MRK
Merck
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

Log in to InvestorsHub
Register Now

NYSE, AMEX, and ASX quotes are delayed by at least 20 minutes.
All other quotes are delayed by at least 15 minutes unless otherwise stated.